(Q36956933)

17 August 2017

Patterns and causes of suboptimal response to tenofovir-based therapy in individuals coinfected with HIV and hepatitis B virus (English)

1 reference

17 August 2017

1 reference

1 reference

1 reference

Margaret Littlejohn

9

0 references

Peter Revill

Peter A Revill

8

0 references

Sharon R. Lewin

Sharon R Lewin

6

0 references

Jennifer Hoy

Jennifer F Hoy

10

0 references

Kiat Ruxrungtham

12

Kiat Ruxrungtham

1 reference

17 August 2017

15

Chloe L Thio

1 reference

17 August 2017

2

Eric C Seaberg

1 reference

17 August 2017

5

Gregory J Dore

1 reference

17 August 2017

Gail V Matthews

1

1 reference

17 August 2017

Anchalee Avihingsanon

3

1 reference

17 August 2017

Scott Bowden

4

1 reference

17 August 2017

Joe Sasadeusz

7

1 reference

17 August 2017

Robert Finlayson

11

1 reference

17 August 2017

Melissa Saulynas

13

1 reference

17 August 2017

Stephen Locarnini

14

1 reference

17 August 2017

language of work or name

English

0 references

publication date

11 January 2013

1 reference

Clinical Infectious Diseases

17 August 2017

1 reference

17 August 2017

56

1 reference

17 August 2017

9

1 reference

17 August 2017

e87-94

1 reference

Combination HBV therapy is linked to greater HBV DNA suppression in a cohort of lamivudine-experienced HIV/HBV coinfected individuals

17 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3693490

Low-level viremia persists for at least 7 years in patients on suppressive antiretroviral therapy

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3693490

Clinical implications of HIV and hepatitis B co-infection in Asia and Africa

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3693490

Intracellular metabolism and in vitro activity of tenofovir against hepatitis B virus

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3693490

Longitudinal data analysis for discrete and continuous outcomes

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3693490

Long-term therapy with tenofovir is effective for patients co-infected with human immunodeficiency virus and hepatitis B virus

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3693490

A randomized trial of combination hepatitis B therapy in HIV/HBV coinfected antiretroviral naïve individuals in Thailand

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3693490

Anti-hepatitis B virus efficacy of tenofovir disoproxil fumarate in HIV-infected patients

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3693490

Selection of hepatitis B virus polymerase mutations in HIV-coinfected patients treated with tenofovir.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3693490

Intermittent HIV-1 viremia (Blips) and drug resistance in patients receiving HAART.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3693490

An open-label study of tenofovir in HIV-1 and Hepatitis B virus co-infected individuals

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3693490

Clinical and virological outcomes in HIV-infected patients with chronic hepatitis B on long-term nucleos(t)ide analogues

4 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23315316

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Improvements in parameters of end-stage liver disease in patients with HIV/HBV-related cirrhosis treated with tenofovir

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23315316

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1093/CID/CIT002

1 reference

17 August 2017

1 reference

17 August 2017

PubMed publication ID

23315316

1 reference